Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : BNTX save search
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
Published: 2024-04-24 (Crawled : 13:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: -5.77%
H: 0.0%
C: 0.0%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 0.24%
H: 0.0%
C: 0.0%
business update for financial results
BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
Published: 2024-04-22 (Crawled : 11:00) - globenewswire.com
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 1.33%
H: 2.12%
C: 1.3%
first report update financial results
Understanding the mRNA Therapeutics Market's -8.6% Decline: Insights from BCC Research
Published: 2024-04-10 (Crawled : 14:30) - prnewswire.com
OMGA | $2.335 -0.21% -0.21% 200K
|
|
| O: -0.33%
H: 0.17%
C: 0.0%
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: -0.67%
H: 1.36%
C: 0.0%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: -1.69%
H: 0.97%
C: 0.14%
mrna research therapeutics
Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer
Published: 2024-04-07 (Crawled : 20:20) - globenewswire.com
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 1.38%
H: 0.2%
C: -1.27%
candidate cancer pancreatic tumor immunotherapy for response show
Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update
Published: 2024-03-27 (Crawled : 20:00) - globenewswire.com
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: -0.08%
H: 1.01%
C: -0.7%
MTNB | $0.1818 0.17% 0.0% 520K
|
Health Technology
|
| O: -3.38%
H: 2.32%
C: -3.25%
business update biopharma financial results
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
Published: 2024-03-20 (Crawled : 10:00) - globenewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: -1.37%
H: 0.0%
C: -1.58%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.62%
H: 0.45%
C: 0.34%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: -5.51%
H: 1.33%
C: 1.2%
management commercial
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
Published: 2024-03-20 (Crawled : 11:00) - biospace.com/
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: -5.51%
H: 1.33%
C: 1.2%
AUTL | $4.23 -5.58% -5.91% 2.7M
|
Health Technology
|
| O: 1.45%
H: 5.33%
C: 4.13%
year update financial results
Lipid-Nanoparticle Based Genomic Medicines Market worth $32.5 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
Published: 2024-03-18 (Crawled : 14:00) - prnewswire.com
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -2.73%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 0.48%
H: 1.18%
C: 0.08%
ABUS | $2.74 -0.36% -0.36% 340K
|
Health Technology
|
| O: 0.38%
H: 0.38%
C: -3.42%
report genomic market
Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
Published: 2024-03-14 (Crawled : 11:00) - globenewswire.com
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 0.11%
H: 0.3%
C: -1.21%
AUTL | $4.23 -5.58% -5.91% 2.7M
|
Health Technology
|
| O: 1.82%
H: 12.19%
C: 2.15%
business year therapeutics financial results
EAF INVESTOR NOTIFICATION: Kessler Topaz Meltzer & Check, LLP Announces Lead Plaintiff Deadline on March 25, 2024 in Securities Fraud Class Action Lawsuit Filed against GrafTech International Ltd.
Published: 2024-03-12 (Crawled : 01:00) - prnewswire.com
EAF | $1.65 5.1% 0.0% 5.2M
|
Producer Manufacturing
|
| O: -0.56%
H: 8.38%
C: 4.47%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 0.54%
H: 0.18%
C: -1.13%
international deadline
CTXTQ ALERT: Levi & Korsinsky, LLP Commences an Investigation of Cyxtera Technologies, Inc. (CYXTQ) f/k/a Starboard Value Acquisition (SVAC)
Published: 2024-03-12 (Crawled : 19:00) - prnewswire.com
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 0.01%
H: 0.98%
C: -1.87%
acquisition
ALVR IMPORTANT DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important March 19 Deadline in Securities Class Action - ALVR
Published: 2024-03-12 (Crawled : 19:00) - prnewswire.com
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 0.01%
H: 0.98%
C: -1.87%
ALVR | $0.7826 -1.05% -1.06% 150K
|
Health Technology
|
| O: -0.14%
H: 1.49%
C: -1.43%
deadline global
CMAX ALERT: Levi & Korsinsky, LLP Commences an Investigation of CareMax, Inc. (CMAX) f/k/a Deerfield Healthcare Technology Acquisitions Corp. (DFHT)
Published: 2024-03-12 (Crawled : 19:00) - prnewswire.com
CMAX | $3.27 -6.3% -6.73% 180K
|
Manufacturing
|
| O: -0.61%
H: 4.46%
C: -10.62%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 0.01%
H: 0.98%
C: -1.87%
acquisitions technology
BNTX DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX
Published: 2024-03-12 (Crawled : 19:00) - prnewswire.com
NARI S | $38.18 2.88% 2.8% 1.4M
|
Health Technology
|
| O: -0.43%
H: 2.53%
C: -1.41%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 0.01%
H: 0.98%
C: -1.87%
deadline
Kessler Topaz Meltzer & Check, LLP Investigates The Chemours Company for Potential Securities Violations and Encourages Investors to Contact Firm
Published: 2024-03-11 (Crawled : 23:00) - prnewswire.com
AMPL | $9.91 0.81% 0.81% 190K
|
|
| O: 0.27%
H: 0.54%
C: -0.63%
CC | $27.08 1.31% 0.0% 1M
|
Process Industries
|
| O: -0.34%
H: 1.38%
C: 0.27%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 0.54%
H: 0.18%
C: -1.13%
company potential
BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024
Published: 2024-03-11 (Crawled : 12:00) - globenewswire.com
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: -0.19%
H: 7.03%
C: 5.71%
BNTX Investors Have Opportunity to Lead BioNTech SE Securities Fraud Lawsuit
Published: 2024-03-08 (Crawled : 16:00) - prnewswire.com
BTAFF | $29.19 44.6% 1.4K
|
Consumer Non-Durables
|
| O: 0.5%
H: 0.13%
C: -0.94%
BTI | $29.49 -0.24% -0.07% 6.4M
|
Consumer Non-Durables
|
| O: -0.07%
H: 0.58%
C: 0.44%
DADA | News | $2.0 7.53% 7.0% 1.4M
|
Technology Services
|
| O: 1.63%
H: 0.58%
C: -7.6%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 0.0%
H: 0.48%
C: 0.2%
ADM Investors Have Opportunity to Lead Archer-Daniels-Midland Company Securities Fraud Lawsuit
Published: 2024-03-08 (Crawled : 16:00) - prnewswire.com
ADM | $61.56 -0.37% -0.6% 3.7M
|
Process Industries
|
| O: -0.07%
H: 1.9%
C: 1.11%
BROG | $1.07 -5.66% 110K
|
Finance
|
| O: 5.66%
H: 6.59%
C: 6.59%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 0.0%
H: 0.48%
C: 0.2%
company
Kessler Topaz Meltzer & Check, LLP Reminds BioNTech SE Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm
Published: 2024-03-07 (Crawled : 22:00) - prnewswire.com
MBLY | $31.12 2.27% 2.22% 3M
|
|
| O: 1.06%
H: 0.49%
C: -3.77%
AMPL | $9.91 0.81% 0.81% 190K
|
|
| O: 1.08%
H: 0.89%
C: -1.38%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 0.0%
H: 0.48%
C: 0.2%
deadline
Lost Money on BioNTech SE(BNTX)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
Published: 2024-03-07 (Crawled : 11:00) - prnewswire.com
AMLX A | $1.88 -3.59% -3.72% 1.4M
|
|
| O: -0.68%
H: 1.37%
C: 0.26%
INMD | $17.36 -0.06% -0.06% 780K
|
Health Technology
|
| O: 0.88%
H: 0.52%
C: -1.26%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 0.0%
H: 0.55%
C: -0.33%
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.